Drug Shortage Report for LUMIGAN
Report ID | 5736 |
Drug Identification Number | 02245860 |
Brand name | LUMIGAN |
Common or Proper name | Lumigan 0,03% 3 mL |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BIMATOPROST |
Strength(s) | 0.03% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 3ML |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2011-04-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-04-05 | French | Compare |
v1 | 2017-04-05 | English | Compare |
Showing 1 to 2 of 2